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Abstract
The female steroid, 17b-estradiol (E2), is important for pancreatic b-cell function and acts via at least three estrogen
receptors (ER), ERa, ERb, and the G-protein coupled ER (GPER). Using a pancreas-specific ERa knockout mouse generated
using the Cre-lox-P system and a Pdx1-Cre transgenic line (PERaKO2/2), we previously reported that islet ERa suppresses
islet glucolipotoxicity and prevents b-cell dysfunction induced by high fat feeding. We also showed that E2 acts via ERa to
prevent b-cell apoptosis in vivo. However, the contribution of the islet ERa to b-cell survival in vivo, without the contribution
of ERa in other tissues is still unclear. Using the PERaKO2/2mouse, we show that ERamRNA expression is only decreased by
20% in the arcuate nucleus of the hypothalamus, without a parallel decrease in the VMH, making it a reliable model of
pancreas-specific ERa elimination. Following exposure to alloxan-induced oxidative stress in vivo, female and male
PERaKO2/2 mice exhibited a predisposition to b-cell destruction and insulin deficient diabetes. In male PERaKO2/2 mice,
exposure to E2 partially prevented alloxan-induced b-cell destruction and diabetes. ERa mRNA expression was induced by
hyperglycemia in vivo in islets from young mice as well as in cultured rat islets. The induction of ERa mRNA by
hyperglycemia was retained in insulin receptor-deficient b-cells, demonstrating independence from direct insulin
regulation. These findings suggest that induction of ERa expression acts to naturally protect b-cells against oxidative injury.
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Introduction
The female steroid, 17b-estradiol (E2), is important for
pancreatic b-cell function in mammals [1–4]. E2 acts through at
least three estrogen receptor(ER)s in b-cells, ERa ER b and the G-
protein coupled ER (GPER). These ERs are expressed in rodent
and human b -cells in both sexes, where they exhibit a
predominant extranuclear localization [3,5]. The islet ERa is
important for enhancing insulin biosynthesis in vivo via an
extranuclear ERa-dependent mechanism that amplifies the effect
of glucose in stimulating the insulin gene promoter [6,7]. The islet
ERa also suppresses excess de novo lipogenesis, which prevents
glucolipotoxic b-cell failure in rodent models of type 2 diabetes
(T2D) [8]. E2 also acts as a survival hormone that prevents b-cell
apoptosis in vivo in both sexes at physiological concentrations. This
protection is lost in mice globally deficient in ERa [9]. In cultured
mouse and human islets, E2 protection is mediated mainly via
ERa and GPER, and it protects from diabetes-associated injury
resulting from oxidative stress and pro-inflammatory cytokines
[5,9-11]. Further, during pancreatic islet transplantation, use of an
ERa-selective agonist enhances human islet graft survival, thus
protecting islet functional mass [12]. Overall, global expression of
ERa is necessary for islet survival in mice, and pharmacological
activation of ERa protects islet survival in culture and following in
vivo treatment. Nonetheless, the direct and singular impact of ERa
in islet b-cells on islet survival in vivo –without contribution from
the effects of ERa action in other tissues–has not been addressed.
In this study we used the PERaKO2/2 mouse to examine the role
of islet ERa in islet survival from alloxan induced-oxidative stress
in vivo.
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Materials and Methods
Generation of mutant mice and animal care
Pancreas specific ERa knockout mice were generated using the
Cre-lox-P system and a Pdx1-Cre transgenic line (PERaKO2/2)
as previously described [7]. Pdx1-Cre mice were bred onto the cre-
inducible Rosa26-LacZ line at the University of Michigan. Animal
had free access to food and water. They were kept on a 12-h light/
dark cycle. All animal experiments were approved by Northwest-
ern University or University of Michigan Institutional Animal
Care and Use Committee.
Induction of experimental diabetes and tissue collection
Diabetes was induced in 10–12 week-old female and male mice
by a single intraperitoneal (IP) injection of 150 mg/kg of alloxan
(ALX) (2,4,5,6-Tetraoxypyrimidine) (Sigma-Aldrich) freshly pre-
pared in sterile cold saline (0.9%). Mice ERalox+/+ were used as
control for PERaKO2/2 mice. Blood glucose was measured every
48 h after ALX injection using One Touch Ultra Glucose Monitor
(Lifescan). At day 11 after ALX injection, mice were killed and
blood and pancreata were collected.
In vivo drug administration
17b-Estradiol (4 mg/25 g); Tocris Biosciences) and vehicle (10%
ethanol and 90% sesame oil) were administered subcutaneously
(s.c.) twice daily for two days.
Pancreas insulin concentration
Tails of the pancreata were collected, weighed, and homoge-
nized in acid/ethanol. Then, pancreas homogenates were
centrifuged, and supernatants were used to measure pancreas
insulin concentration by radioimmunoassay (Linco) as described
[7].
Plasma insulin concentrations
Plasma insulin concentrations were measured by ELISA
(Millipore).
Pancreas immunohistochemistry
Deparaffinized pancreatic sections (5 mm) were blocked for
30 min with blocking solution (20% Fetal Bovine Serum + 2%
Roche Blocking Reagent). Sections were incubated overnight with
primary antibodies and 1–2 h with secondary antibodies at room
temperature with the following primary antibodies: guinea pig
anti-human insulin (1:1000; Linco Research), rabbit anti-glucagon
(1:1000, Linco Research), rat anti-mouse CD31 (1:400; BD
Biosciences). Secondary antibodies FITC-conjugated donkey
anti-guinea pig, CY3-conjugated donkey anti-rabbit, AMCA-
conjugated donkey anti-guinea pig, and CY3-conjugated goat
anti-rat (Jackson ImmunoResearch Laboratories) were used at
concentrations recommended by the manufacturer. The nuclei
were stained with DAPI (Invitrogen, Molecular Probes). Images
were obtained with either Nikon Eclipse E400 microscope or
Tissue Genostics Tissue/Cell High Throughput Imaging and
Analysis System at Northwestern University Cell Imaging Facility.
Brain immunohistochemistry
Perfusion and immunohistochemistry were performed as
previously described [13]. Briefly, mice were anesthetized with a
lethal dose of intraperitoneal pentobarbital (150 mg/kg) and
transcardially perfused with sterile PBS and then either 4%
paraformaldehyde or 10% formalin. Brains were removed, post-
fixed overnight and dehydrated in a 30% sucrose solution.
Following cryoprotection, brains were sectioned into 30 mm
coronal slices, collected in four consecutive series and stored at
220uC until further use. For immunohistochemistry, brain
sections were pretreated with ice-cold methanol, 0.3% glycine
and 0.3% SDS before blocking. Sections were then incubated with
primary antibodies either rabbit anti-ERa (1:1000, Sigma) or goat
anti-bGal (1:1000, Biogenesis Ltd) overnight at 4uC. Detection of
primary antibodies was done by either immunofluorescence using
secondary antibodies anti-rabbit Alexa 488, anti-goat Alexa 568,
both 1:200 dilution (Invitrogen) or using the avidin –biotin/
diaminobenzidine method (secondary antibody anti-rabbit –biotin,
1:200 dilution).
Cell counts and statistic
Stained sections were imaged using Leica microscope using 10X
and 20X air objectives and processed using Adobe Photoshop
CSII (Adobe Systems, San Jose, CA). Photoshop was only used to
overlay matched images in different RGB channels such that dual-
labeled cells would become apparent and could be quantified as
described [13].
Calculation of pancreatic b-cell mass
b-cell area was measured in insulin-stained 5 mm thick
pancreatic sections. Three to four sections per tissue were
randomly chosen for morphometric analysis. Insulin positive area
was determined by using ImageJ 1.37v program. To calculate b-
cell mass (mg), insulin positive area was divided by pancreas area
and then multiplied by pancreas weight.
Calculation of vessel density in islets
Blood vessel density was calculated by dividing the mouse-
CD31-positive area by the insulin-positive islet area by using
ImageJ 1.37v program.
Rat model of glucolipotoxicity
Two-month and 6-month old male Wistar rats (Charles River,
St.-Constant, QC), were maintained hyperglycemic and hyperli-
pedimic for 72 hours, following a co-infusion of 70% dextrose plus
20% Intralipid, compared to their 0,9% saline infused controls as
described [14].
Islets isolation
At the end of infusion, islets were isolated by pancreas
collagenase digestion as described [14].
Rat islets culture
Wistar rat islets were pre-cultured for a week in serum-free
RPMI medium supplemented with 5 g/L BSA (37uC, humidified
atmosphere containing 5% CO2). Islets were further cultured for
18 h or 1 week in the same medium containing 5, 10 or 30 mM
glucose (medium was renewed every other day) [15].
Mouse model of moderate hyperglycemia
To study ERa expression under mild hyperglycemia conditions,
a 4 days glucose infusion in mice was performed as is described in
[16]. Briefly, C57bl/6J male mice of 8–12 weeks-old and 20–25 g
received a 4 days infusion of saline or 50% glucose. After this, mice
were anesthetized and islets isolated by digestion with 1.7 ml/cc
Collagenase P (Sigma) [9].
bIRKO cell culture
We used insulin-secreting cell lines established from groups of
bIRKO, and Lox control mice as was described previously
The Islet ERa Protects against Oxidative Stress
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[17,18]. Cells were maintained at 37uC and 5% CO2 in
Dulbecco’s modified Eagle’s medium (DMEM) containing
25 mM glucose, 10% fetal bovine serum, and penicillin and
streptomycin. Experiments were performed using 80–90% con-
fluent cells. Lox and bIRKO cells were seeded in 6-well plates and
incubated for 24 h to recover. Cells were first washed with PBS
before incubating in 16.7 or 33 mM glucose in DMEM containing
10% serum and penicillin and streptomycin for 3 days.
Q- PCR
Total RNA was extracted using RNeasyH Micro kit (Qiagen,
Valencia, CA) for islets or RNeasyH kit (Qiagen, Valencia, CA) for
cells according to the manufacturer’s protocols. cDNA was
prepared from 1 mg of total RNA using the High Capacity cDNA
Reverse Transcription Kit (Invitrogen) with random hexamer
primers, according to the manufacturer’s instructions Real-time
PCR amplification of ERa and Tbp (TATA-box binding protein)
cDNAs was carried out i on a CFX96 using iQ-SYBR green
supermix (Bio-Rad, Hercules, CA). Results were normalized to
TBP expression and expressed as arbitrary units. Primer sequences
are the following: Rat islets: 59ACCCTTCACCAATGACTCC-
TATG-39 and 59-TCAGCATTTCTGGCACGAAGT-39for TBP
and -59AATTCTGACAATCGACGCCAG39 and 59-GTGCT-
TCAACATTCTCCCTCCTC-39 for Era. Mouse islets and cells:
59-ACCCTTCACCAATGACTCCTATG-39 and 59-ATGATG-
ACTGCAGCAAATCGC-39 for TBP and 59-GCTTCTCTT-
GGCCTGTACTT-39 and 59-CTCTCCCAGTTTCCACATC-
TT-39 for ERa
Statistical analysis
Data are presented as mean 6 SEM unless otherwise stated.
Data were analyzed by Student’s t test. A value of p,0.05 was
considered statistically significant.
Results
Recombination of ERa in hypothalamic neurons of
PERaKO2/2 mice
To investigate the role of pancreatic ERa on b-cell biology in
vivo, we used PERaKO2/2 mice in which ERa was inactivated in
all pancreatic lineages using a Pdx1-Cre transgenic mouse [7,8].
Because Pdx1-Cre transgenic mice were reported to promote
recombination in nutrient sensing hypothalamic neurons [19], we
first sought to determine whether recombination of ERa occurs in
the hypothalamus of PERaKO2/2 mice. Accordingly, using a
transgenic Pdx1-Cre/LacZ mouse [19], we observed that Pdx1 is
co-expressed with ERa in ,26% of neurons of the ventromedial
hypothalamus (VMH), ,17% of neurons in the preoptic area
(POA), and ,15% of neurons of the arcuate nucleus (ARC)
(Fig. 1A–B). Female PERaKO2/2 mice exhibited a 20% decrease
in the number of ERa positive cells in the ARC, without a parallel
decrease in the VMH (Fig. 1D–F). They also exhibited decreased
fertility (data not shown), suggesting that ERaexpression was also
decreased in the POA.
No alteration in islet vascularization in absence of ERa
E2 stimulates angiogenesis and promotes endothelial cell
recovery after injury [13–17]. We previously observed that
estrogens improve islet revascularization during islet transplanta-
tion [12]. Thus, prior to exploring islet predisposition to oxidative
stress, we sought to determine whether islet vascularization was
altered in female PERaKO2/2 mice. Because loss of ERa in b-
cells or in endothelial cells can alter endothelial cell function via
paracrine or endocrine mechanisms, respectively, we studied
vascular density in PERaKO2/2 and mice globally deficient in
ERa (ERaKO2/2). When we quantified the endothelial cell area
in pancreas section using the mouse endothelial cell marker CD31,
we observed no difference in islet vascularization among
ERaKO2/2, PERaKO2/2 and female control mice (Fig. 2).
The absence of islet vascular defects demonstrated that ERa was
not essential for islet angiogenesis in mice.
The absence of islet ERa predisposes to oxidative stress-
induced diabetes in mice
We induced oxidative stress in b-cells in vivo using a single high-
dose injection of alloxan (ALX; 150 mg/kg of body weight), which
augments the generation of reactive oxygen species (ROS) in
pancreatic islets [20]. We initially observed that female C57BL/6
mice were protected from ALX-induced diabetes (Fig. 3). Next, we
induced oxidative stress in b-cells of PERaKO2/2 female mice. In
basal conditions (time= 0, prior to ALX injection), control and
PERaKO2/2 female mice displayed similar blood glucose
(Fig. 4A–B) and insulin concentrations (data no shown). They
also exhibited normal islet architecture, with insulin-producing b-
cells in a central location and glucagon-producing a-cells at the
periphery (Fig. 4D). PERaKO2/2 female mice showed a trend
toward decreased pancreatic insulin concentration, an observation
that was consistent with the known effect of ERa in stimulating
insulin synthesis [6,7]. Following exposure to ALX, control female
mice showed relative protection compared to PERaKO2/2
female mice. Control female mice displayed only a minor increase
in blood glucose despite hypoinsulinemia and an 87% decrease in
b-cell mass and pancreatic insulin concentration (Fig. 4C–F). This
finding was consistent with the fact that only 20% of b-cells are
needed to maintain euglycemia [12]. In contrast, relative to
controls, exposure of PERaKO2/2 female mice to ALX, induced
marked hyperglycemia and insulin deficiency that resulted from a
more severe b-cell destruction (97%) and decrease in pancreatic
insulin concentrations (Fig. 4A–F). Thus, PERaKO2/2 female
mice exhibited a predisposition to alloxan-induced b-cell destruc-
tion. Note that we did not observe differences in a-cell density
between alloxan-injected control and PERaKO2/2 female mice.
Regarding males, control and PERaKO2/2 mice were
normoglycemic and normoinsulinemic in basal conditions
(Fig. 5A–C), and displayed normal islet architecture (Fig. 5D).
After ALX exposure, both control and PERaKO2/2 male mice
developed hyperglycemia and insulin deficiency and exhibited
decreased b-cell mass and pancreatic insulin concentrations.
However, the reduction in all of these parameters was more
dramatic in PERaKO2/2 than in control mice (Fig. 5A–F). In
addition, after E2 administration, we observed partial protection
from alloxan-induced b-cell destruction and insulin deficiency in
both controls and PERaKO2/2 male mice (Fig. 5A–F). Thus, as
observed in females, male PERaKO2/2 mice exhibited a
predisposition to alloxan-induced b-cell destruction (although to
a lesser extent), but estrogen still provided some protection from
alloxan in the absence of islet ERa. Note that unlike in the case of
Fig.3, experiments of ALX injections described in Fig.4 and 5 were
performed independently in male and female mice. Therefore,
males and female mice described in in Fig.4 and 5 are not
comparable with regard to the female protection from diabetes
observed in Fig.2.
Altered islet ERa expression during hyperglycemia and
hyperinsulinemia
Having determined that islet ERa is important to oxidative
stress protection in vivo, we next sought to determine whether ERa
The Islet ERa Protects against Oxidative Stress
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mRNA expression was altered in islets during hyperglycemia-
induced oxidative stress in vivo. We used two established rodent
models of glucotoxicity and glucolipotoxicity. We first studied ERa
mRNA expression in islets from non-diabetic Wistar rats that
received a 72 h glucose and intralipid co-infusion to mimic
glucolipotoxicity (mean glucose 15 mM) [14]. Under these
conditions, hyperglycemia was associated with increased ERa
mRNA expression in 2 month-old rat islets (Fig. 6A). However,
hyperglycemia did not increase ERa mRNA in islets from 6
month-old rats. We next studied ERa mRNA expression in a
mouse model of mild hyperglycemia that was achieved by a 4-day
glucose infusion (mean glucose 7 mM) [16]. In this model, we
observed no increase in islet ERa mRNA (Fig. 6B). To ascertain
whether ERa mRNA induction under severe hyperglycemic
conditions resulted from a direct glucose effect on islets, we
further studied ERa mRNA expression in Wistar rat islets cultured
one week in hyperglycemic conditions [15]. ERa expression was
increased when glucose was raised from 5 mM to 10 mM, but
there was no further increase at 30 mM (Fig. 6C). Therefore,
moderate to severe hyperglycemia [15] is associated with increased
ERa mRNA expression in vitro and in vivo in rats.
ERa expression in insulin resistant b-cells
We hypothesized that the increased ERa mRNA expression in
islets exposed to hyperglycemia could be due to the stimulatory
effect of high glucose or to the impact of elevated insulin on the
IR in the islets. To address this question, we quantified ERa
expression in b-cells isolated from normal and b-cell IR knockout
(bIRKO) mice [18]. These islets were cultured in hyperglycemic
conditions to increase insulin secretion. Consistent with the effect
of glucose described above (Fig. 5A), ERa mRNA expression was
increased in both control (lox/lox) and bIRKO b-cells when
glucose was increased from 16.7 mM to 33 mM (Fig. 6D).
However, at both glucose concentrations, ERa mRNA expres-
sion was higher in bIRKO compared to lox/lox b-cells,
demonstrating that insulin action in b-cells inhibits ERa mRNA
expression.
Figure 1. ERa expression in PERaKO2/2 hypothalamus. Pdx1-Cre/Lacz mouse and immunofluorescence in frontal brain sections from
PERaKO2/2 mice. Pdx-1 expression (red) marked by beta galactosidase (b-gal) and ERa (green) show PDX-1 and ERa co-expression in the
ventromedial hypothalamus (VMH), the preoptic area and arcuate nucleus (ARC) (A–B). and quantification (C) Bar represents 250 mm. Representative
images of immunohistochemical analisys showing ERa expression in frontal brain sections from ERa fl/fl, (D) ERaKO2/2 (E) and PERaKO2/2 (F) mice
Pictures taken at 10X magnification and quantification (G).
doi:10.1371/journal.pone.0087941.g001
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Discussion
Having established that ERa is not essential to islet angiogenesis
in mice, we focused on the role of ERa in protecting islets from
glucotoxicity and oxidative stress in vivo and report that both male
and female mice lacking ERa selectively in the pancreas are
more susceptible to alloxan-induced b-cell destruction, insulin
deficiency, and hyperglycemia. Although these experiments
demonstrated a mild decrease in ERa mRNA expression in
hypothalamus of PERaKO2/2 mice, the absence of alteration in
energy homeostasis [7,8] and the pancreas-specific phenotype
observed in this model both suggest that the PERaKO2/2
phenotype results exclusively from pancreatic elimination of ERa.
Figure 2. No difference in islet vascularization between ERaKO2/2, PERaKO2/2 and control female mice. (A) Representative sections showing
immunofluorescence staining for insulin (blue) and mouse CD31 (red) positive cells in control, PERaKO2/2, and ERaKO2/2 pancreata. (B)
Quantification of islets vessel density. Values represent the mean6SEM, n = 3–4/group. Bar represents 100 mm.
doi:10.1371/journal.pone.0087941.g002
Figure 3. Gender dimorphism in alloxan sensitivity. Comparison of blood glucose values and area under the curve for glucose (AUC) above
basal (T0) between male and female C57bl/6J wild type mice. Blood glucose was measured every 48 h for 8 days after injection of 150 mg/kg of
alloxan (ALX). Values represent the mean6SEM, n= 4/group.*P,0.05.
doi:10.1371/journal.pone.0087941.g003
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Figure 4. Female PERaKO2/2 mice are susceptible to ALX-induced diabetes. (A) Random-fed blood glucose from day 0 to day 11 after
injection of either 150 mg/Kg of ALX or saline. (B) Corresponding area under the curve (AUC) for glucose. (C) Ratio of random-fed of insulin (ng/ml)
and glucose (mg/dl) at day 11 was used as an index of insulin deficiency. (D) Representative sections showing immunofluorescent histochemical
analysis of pancreas sections stained for insulin (green) and glucagon (red) in control ERalox+/+ and PERaKO2/2 mice (E) b-cell mass quantification.
(F) Pancreas insulin concentration 11 day after ALX injection. Values represent the mean6SEM, n = 4–13/group. *P,0.05, **P,0.001 ***P,0.01, Bar
represents 100 mm.
doi:10.1371/journal.pone.0087941.g004
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Figure 5. Male PERaKO2/2 mice are susceptible to ALX-induced diabetes. (A) Random-fed blood glucose from day 0 to day 11 after
injection of either 150 mg/Kg of ALX or saline. (B) Corresponding area under the curve (AUC) for glucose. (C) Ratio of random-fed of insulin (ng/ml)
and glucose (mg/dl) at day 11 was used as an index of insulin deficiency. (D) Representative sections showing immunofluorescent histochemical
analysis of pancreas sections stained for insulin (green) and glucagon (red) in control ERalox+/+ and PERaKO2/2mice (E) b-cell mass quantification (F)
Pancreas insulin concentration 11 day after ALX injection. Values represent the mean6SEM, n = 4–19/group. *P,0.05, ***P,0.001, # =0.06. Bar
represents 100 mm.
doi:10.1371/journal.pone.0087941.g005
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Since alloxan induces oxidative stress, these findings demonstrate
that normal islet ERa expression is required to protect b-cells from
oxidative stress-induced apoptosis in vivo in both sexes. The
harmful effect of ERa deletion is more pronounced in female
mice, presumably as a result of higher E2 serum concentrations
that are required to activate the islet ERa in this gender.
Nonetheless, the negative effect of ERa deletion on islet cells is also
observed in males, demonstrating that islet protection by ERa is sex
independent. We previously reported that mice of both sexes globally
lacking ERa (aERKO2/2) were predisposed to streptozotocin-
induced b-cell apoptosis and insulin-deficient diabetes [9]. However,
the beneficial actions of estrogen on glucose homeostasis results from
the combined actions of ERa in different tissues [2]. Thus aERKO2/2
mice globally lacking estrogen action in skeletal muscle, adipose tissue,
and the brain become obese and insulin resistant as well as mildly
hyperglycemic. This could produce additional b-cell stress that would
synergize streptozotocin toxicity to alter b-cell survival. The current
study demonstrates that loss of ERa selectively in islets – while ERa is
normally expressed in other tissues – is sufficient to induce b-cell
destruction in the presence of another b-cell stress and without any
influence of altered body weight [2,7]. Given the mild decrease in ERa
expression observed in PERaKO2/2 hypothalamic ARC, this
abnormality is unlikely to play a role in the PERaKO2/2 phenotype.
We previously reported that ERa gene dosage plays a role in the
islet protection from streptozotocin injury because heterozygous
aERKO2/2 mice of both sexes were predisposed to streptozot-
ocin-induced diabetes [9]. Thus, increased ERa expression could
function to protect b-cells against oxidative stress. To evaluate this
hypothesis, we used established models of glucolipotoxicity and
moderate hyperglycemia. We observed that in both cultured rat
islets and in mouse islets in vivo, moderate to severe hyperglycemia
increased ERa mRNA. In cultured mouse islets and MIN6 cells,
short term exposure to high glucose is also associated with an
increase in ERa mRNA expression [21]. Overexpression of ERa
prevents apoptosis in PC12 neuronal cells, [22] and in the SK-N-
MC human neuroblastoma cell line [23]. In contrast, in a model of
moderate hyperglycemia, ERa mRNA is not upregulated in islets.
During hyperglycemia, is ERa induced by glucose itself or by
insulin? In IR-deficient b-cells cultured in high glucose, ERa
mRNA was increased compared to normal cells. This demon-
strates that compared to hyperglycemia, insulin action in b-cells is
unlikely to play a direct role in inducing ERa mRNA in b-cells.
Figure 6. Messenger RNA levels of ERa were measured by QT-PCR from (A) 2 and 6 months-old male Wistar rats after 72 h glucose and intralipid co-
infusion.(B) C57bl/6J male mice of 8–12 weeks-old after a 4 day glucose infusion. (C) Wistar rat islets cultured for one week in glucose 5, 10 or
30 mM. (D) b-cells cell line from control Lox/Lox and bIRKO mice cultured in 16.7 or 33 mM glucose. Values represent the mean6SEM, n= 4–5/group.
*P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0087941.g006
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Thus, the induction of ERa expression by hyperglycemia could
function as a b-cell protection against oxidative injury when
hyperglycemia reaches a threshold beyond which oxidative injury
occurs. Further, glucolipotoxicity, upregulates ERa mRNA in
young rats, but this feature is lost in older animals. Since ERa
improves b-cell survival [3,5,9], the loss of ERa induction in old
islets may alter their resistance to diabetic injuries, as we observe in
the PERaKO2/2 mouse. This weakness may further increase b-
cell susceptibility to oxidative injuries such as glucotoxicity, setting
the stage for b-cell failure in old age.
ERa protection from oxidative stress could involve a combina-
tion of rapid antiapoptotic actions that are independent of nuclear
events and that potentially lead to alteration in protein phosphor-
ylation [3,24]. Alternatively, it could involve a more classical
genomic mechanism that induces an anti-inflammatory cascade
via expression of the liver receptor homolog [25].
In conclusion, ERa mRNA expression is induced in islets from
young mice by exposure to hyperglycemia and oxidative stress,
and mice of both sexes that selectively lack ERa in the islets are
susceptible to both oxidative stress in b-cells and insulin-deficient
diabetes.
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